Works matching IS 14248247 AND DT 2022 AND VI 15 AND IP 2


Results: 153
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Experimental Nuclear Medicine Meets Tumor Biology.

    Published in:
    Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 227, doi. 10.3390/ph15020227
    By:
    • Balber, Theresa;
    • Tran, Loan;
    • Benčurová, Katarína;
    • Raitanen, Julia;
    • Egger, Gerda;
    • Mitterhauser, Markus
    Publication type:
    Article
    36

    Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists.

    Published in:
    Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 226, doi. 10.3390/ph15020226
    By:
    • Abdelgawad, Mohamed A.;
    • El-Adl, Khaled;
    • El-Hddad, Sanadelaslam S. A.;
    • Elhady, Mostafa M.;
    • Saleh, Nashwa M.;
    • Khalifa, Mohamed M.;
    • Khedr, Fathalla;
    • Alswah, Mohamed;
    • Nayl, AbdElAziz A.;
    • Ghoneim, Mohammed M.;
    • Abd El-Sattar, Nour E. A.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50